Protagonist Therapeutics
PTGX
#3716
Rank
NZ$4.50 B
Marketcap
$76.50
Share price
3.07%
Change (1 day)
166.96%
Change (1 year)

Operating Margin for Protagonist Therapeutics (PTGX)

Operating Margin as of September 2024 (TTM): 51.77%

According to Protagonist Therapeutics 's latest financial reports and stock price the company's current Operating Margin is 51.77%. At the end of 2023 the company had an Operating Margin of -131.59%.

Operating Margin history for Protagonist Therapeutics from 2018 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-131.59%-72.54%
2022-479.26%4.43%
2021-458.94%102.61%
2020-226.51%-99.33%
2019-33,713.42%26146.44%
2018-128.45%-30.27%
2017-184.20%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
0.00%N/A๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.